Free Resource Friday | Preparing for the BC-ADM Exam Webinar

August 9th, 2019 / Beverly Thomassian / Comments Off on Free Resource Friday | Preparing for the BC-ADM Exam Webinar

Ready to commit to studying? Coach Beverly recommends our Live Seminar in San Diego or our 1 year subscription for those studying for the BC-ADM. Our Live seminar is a 3 day intensive, where four diabetes experts will help explain the complexities of diabetes in easy to understand terms. Join us in San Diego and … Continue reading Free Resource Friday | Preparing for the BC-ADM Exam Webinar

Oral GLP-1 RA lowers Weight and A1c

August 8th, 2019 / Beverly Thomassian / Comments Off on Oral GLP-1 RA lowers Weight and A1c

In a randomized phase 3a study published in Diabetes Care, those taking oral semaglutide monotherapy experienced superior and clinically significant improvements in A1c and weight loss compared to those taking a placebo. Semaglutide (Ozempic) is currently only available as a once a week injectable, belonging to the GLP-1 Receptor Agonists classification. This class of medications … Continue reading Oral GLP-1 RA lowers Weight and A1c

August Newsletter | Diabetes Medications Approved & Supplements Reviewed

August 7th, 2019 / Beverly Thomassian / Comments Off on August Newsletter | Diabetes Medications Approved & Supplements Reviewed

August Newsletter Now Available! In our August Newsletter, we highlight several exciting new releases! Nasal Glucagon has been approved, generic Dapagliflozin has been released, and Cleveland Clinic has synthesized a chart of supplements and their efficacy for people with diabetes! Read this month’s newsletter before August 16 to see how you could get a $50 … Continue reading August Newsletter | Diabetes Medications Approved & Supplements Reviewed

Dapagliflozin biosimilar gets tentative FDA approval

August 6th, 2019 / Beverly Thomassian / Comments Off on Dapagliflozin biosimilar gets tentative FDA approval

The marketing application for a generic version of Farxiga, or dapagliflozin has received tentative approval from the US Food and Drug Administration (USFDA). Alembic Pharmaceuticals received a nod for its abbreviated new drug application for Dapagliflozin Tablets in 5 mg and 10 mg strength. The approved product is therapeutically equivalent to the reference listed drug … Continue reading Dapagliflozin biosimilar gets tentative FDA approval

5 Steps to Stop Sitting and Increase Longevity

August 6th, 2019 / Beverly Thomassian / Comments Off on 5 Steps to Stop Sitting and Increase Longevity

New studies show that sitting for too long can impair health and even shorten life expectancy. It’s difficult to keep active in a world of screens, movie theaters, and desk jobs. However, studies are showing that body awareness and movement is necessary. The goal is to get up at least every hour of sedentary time, … Continue reading 5 Steps to Stop Sitting and Increase Longevity

Question of the Week | August 6, 2019

August 6th, 2019 / Beverly Thomassian / Comments Off on Question of the Week | August 6, 2019

Our Diabetes Detective Team scans the diabetes news to discover the most relevant info that Diabetes Educators need in their daily practice. We post one daily Blog Byte from Monday to Friday. And of course, Tuesday is our Question of the Week. It’s Informative and FREE!  Sign up below! Question of the Week – Aug … Continue reading Question of the Week | August 6, 2019

Getting Back to Basics: How Green is Good

August 5th, 2019 / Beverly Thomassian / Comments Off on Getting Back to Basics: How Green is Good

While most know there are great benefits to getting out in nature, Medical News Today has released a study showing that simply viewing nature can reduce cravings such as smoking, excessive drinking, and unhealthy eating. Walking in nature has been shown to reduce cortisol and improve mood. Now though, research suggests even simply seeing green … Continue reading Getting Back to Basics: How Green is Good

One Stop Shopping | Free CDE® Coach App for Diabetes Educators

August 2nd, 2019 / Beverly Thomassian / Comments Off on One Stop Shopping | Free CDE® Coach App for Diabetes Educators

We are excited to share DANA’s exceptional review of our app! AADE’s Diabetes Advanced Network Access (DANA) reviewed our app and noted exceptional functionality! Plus, the CDE® Coach app received the prestigious mWellth certification. DANA has deemed it the “ultimate one stop shop for practical tools to prepare for the CDE® exam.” “The app offers … Continue reading One Stop Shopping | Free CDE® Coach App for Diabetes Educators

Do topical steroids increase risk of type 2 diabetes?

August 1st, 2019 / Beverly Thomassian / Comments Off on Do topical steroids increase risk of type 2 diabetes?

Based on a study published in Diabetes Care in April 2019, it appears that there is a positive association between use of topical corticosteroids and new incident diabetes. A Danish case-control study collected health care data from people who were diagnosed with new onset Type 2 diabetes in Denmark and the United Kingdom. A total … Continue reading Do topical steroids increase risk of type 2 diabetes?

Gastric Bypass Surgery associated with high type 2 diabetes remission rates

July 31st, 2019 / Beverly Thomassian / Comments Off on Gastric Bypass Surgery associated with high type 2 diabetes remission rates

A recent study conducted by the Aarhus University Hospital in Denmark found that three out of every four persons living with obesity and type 2 diabetes who receive a RYGB ( Roux-en-Y Gastric Bypass) experience remission within one year. Remission is defined as blood glucose levels at non-diabetes range without using diabetes medications. This study … Continue reading Gastric Bypass Surgery associated with high type 2 diabetes remission rates